Join leading experts live from Milan as they crack the code of resistant hypertension in this insightful minisymposium. From cutting-edge diagnostics to the evolving role of beta-blockers and the promise of single-pill combinations, this session explores bold strategies for tackling one of cardiology’s toughest challenges. Don’t miss this dynamic exchange of insights chaired by renowned clinicians R. Kreutz and S. Taddei - a must-watch for anyone shaping the future of hypertension care.

Key Objectives:

• The significant role of sympathetic nervous system overactivity as a primary contributor to RHT.
• Evaluating the position and ongoing relevance of beta-blockers in the treatment plans for patients with RHT.
• Addressing the critical issue of medication adherence and the potential for single-pill combinations (SPCs) to improve it among this patient group.